Ann: Change of Interest of Substantial Holder from PVL, page-7

Just based on cash backing it’s way undervalued, if this becomes a back door listing for another drug then it will fly and that’s what think is happening , hence the sub holder is increasing their holdings.

We have no formal idea of the PVL/ Kenley linkage. We know PVL is a small listed fund manager that looks for stocks that can rise 400%+, read their web site. Meanwhile Kenley is a seasoned bio-tech professional , who currently has an unlisted company, Lateral Pharma, that is working on a number of indications, read their website . The presence of stockbroker Gennardi working with Kenley makes a backdoor listing of Lateral a real possibility.

There is no sign of a bidding war going on for the vehicle, so pretty safe to assume they are working together , but a lot more information is imminent you would think